References
- Meltzer EO, Szwarcberg J, Pill MW. Allergic rhinitis, asthma, and rhinosinusitis: diseases of the integrated airway. J Manag Care Pharm 2004;10:310–7
- Gooch 3rd WM. Antibacterial management of acute and chronic sinusitis. Manag Care Interface 1999;12:92–4
- Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999;103:408–14
- Piccirillo JF. Acute rhinosinusitis: staging, diagnosis/outcomes assessment. Infect Med 1998;15:16–25
- Benninger MS, Sedory Holzer SE, Lau J. Diagnosis and treat- ment of uncomplicated acute bacterial rhinosinusitis: summary of the Agency for Health Care Policy and Research evidence- based report. Otolaryngol Head Neck Surg 2000;122:1–7
- Anon JB, Jacobs MR, Poole MD, et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130(Suppl 1):1–45
- Scheid DC, Hamm RM. Acute bacterial rhinosinusitis in adults: part I. Evaluation. Am Fam Phys 2004;70:1685–92
- Ferguson BJ. Acute and chronic sinusitis: how to ease symptoms and locate the cause. Postgrad Med 1995;97:45–57
- Shalit I, Horev-Azaria L, Fabian I, et al. Immunomodulatory and protective effects of moxifloxacin against Candida albicansinduced bronchopneumonia in mice injected with cyclophosphamide. Antimicrob Agents Chemother 2002;46:2442–9
- Weiss T, Shalit I, Blau H, et al. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines. Antimicrob Agents Chemother 2004;48:1974–82
- Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews, available from www.de.cochrane.org/review/en/ab003539.html [last accessed 15 November 2005]
- Guillemot D, Carbon C, Vauzelle-Kervroëdan F, et al. Inappropriateness and variability of antibiotic prescribing among French office-based physicians. J Clin Epidemiol 1998;51:61–8
- PharMetrics Overview. Available from http://www.pharmetrics.com/h_overview.html [last accessed 14 November 2005]
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:73–83
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: 613–9